Boothbay Fund Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Boothbay Fund Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.06M	Buy	38,300 +3,000	+8%	+$406K	0.08%	290
2026 Q1	$4.51M	Buy	+35,300	New	+$4.41M	0.06%	346
2025 Q3	–	Sell	-10,000	Closed	-$829K	–	2208
2025 Q2	$829K	Buy	+10,000	New	+$798K	0.02%	749
2025 Q1	–	Sell	-130,000	Closed	-$11.7M	–	1832
2024 Q4	$11.7M	Sell	130,000 -98,800	-43%	-$9.57M	0.29%	71
2024 Q3	$22.6M	Buy	228,800 +181,400	+383%	+$17.8M	0.51%	17
2024 Q2	$4.39M	Sell	47,400 -408,400	-90%	-$36.6M	0.1%	267
2024 Q1	$43.3M	Buy	455,800 +308,900	+210%	+$28.7M	0.83%	10
2023 Q4	$13.1M	Sell	146,900 -23,700	-14%	-$1.76M	0.33%	41
2023 Q3	$12.5M	Sell	170,600 -50,800	-23%	-$4.06M	0.3%	56
2023 Q2	$18.4M	Buy	221,400 +129,700	+141%	+$10.8M	0.4%	30
2023 Q1	$6.99M	Buy	91,700 +71,500	+354%	+$5.93M	0.14%	152
2022 Q4	$1.68M	Sell	20,200 -6,600	-25%	-$534K	0.04%	666
2022 Q3	$2.13M	Sell	26,800 -23,700	-47%	-$2M	0.05%	544
2022 Q2	$3.75M	Sell	50,500 -11,100	-18%	-$833K	0.1%	289
2022 Q1	$5.54M	Buy	61,600 +300	+0.5%	+$27.7K	0.13%	182
2021 Q4	$6.86M	Sell	61,300 -3,500	-5%	-$422K	0.16%	137
2021 Q3	$8.15M	Buy	+64,800	New	+$8.34M	0.23%	82

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Boothbay Fund Management's XBI Position: Q2 2026 in Review

Boothbay Fund Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 30% in Q2 2026, buying an estimated $364K and bringing the position to 11,616 shares worth $1.84M. The position accounts for 0.02% of the portfolio, ranked #767.

Boothbay Fund Management first reported a position in XBI in Q1 2017 and has held it in 9 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Boothbay Fund Management held 11,616 shares of State Street SPDR S&P Biotech ETF worth $1.84M as of Q2 2026.
Boothbay Fund Management bought 2,692 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $364K.
State Street SPDR S&P Biotech ETF made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #767 holding.
Boothbay Fund Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 9 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.